Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

09/02/2023 07:30

Feb 9 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Sep 30, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             10.00               9.45             43.31    
                 (+5.8 pct)          (+1.6 pct)       (+22.3 pct) 
  Operating          1.19               1.56              4.05    
                 (-23.8 pct)         (-8.0 pct)       (+7.2 pct)  
  Recurring          1.58               1.58              4.09    
                 (-0.1 pct)          (-8.7 pct)       (+9.7 pct)  
  Net                1.11               1.12              2.97    
                 (-0.3 pct)          (-15.8 pct)      (+10.3 pct) 
  EPS             45.88 yen           46.05 yen       122.42 yen  
  Ann Div                             35.00 yen        37.00 yen  
  -Q2 div                             15.00 yen        17.00 yen  
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T